Genus (CHIX:GNSL) Buyback Yield %: -0.01 (As of Jul. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:GNSL Genus PLC CHIX:GNSL
72 GF Score
Price £21.42
GF Value £20.63
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Genus Buyback Yield %?

Genus CHIX:GNSL -0.83% 72 Buyback Yield % is -0.01 as of Jul. 24, 2026. GuruFocus rates CHIX:GNSL with a GF Score™ of 72/100 and a GF Value™ of £20.63 (Fairly Valued). The stock has 5 warning signs investors should review. Among 738 Biotechnology companies, Genus ranks better than 86.72% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Genus's current buyback yield was -0.01%.


Genus Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Genus's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genus Buyback Yield % Chart

Genus Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Genus Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.01

CHIX:GNSL vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Genus's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genus Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genus's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Genus's Buyback Yield % falls into.


CHIX:GNSL
72GF Score
Genus PLC CHIX:GNSL
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genus Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Genus's Buyback Yield for the fiscal year that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 1344.6048
=0.00%

Genus's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0.1) / 1733.3793
=-0.01%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -0.01 mean?
Genus (CHIX:GNSL) has a Buyback Yield % of -0.01 as of Jul. 24, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Genus and its competitors. According to the industry distribution chart, Genus ranks #98 out of 738 companies in the Biotechnology industry, placing it in the top 13.3%.
Is Genus' Buyback Yield % too high?
Genus' current Buyback Yield % is -0.01. Based on the distribution chart, Genus ranks #98 out of 738 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Genus has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Genus' Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Genus ranks #98 out of 738 companies for Buyback Yield %. This places Genus in the top 13% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Genus and its competitors. Genus's current Buyback Yield % is -0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genus stock overvalued right now?
Based on GuruFocus' analysis, Genus (CHIX:GNSL) is currently considered Fairly Valued. The stock's GF Value™ is £20.63, compared to a current price of £21.42 — trading 3.8% above its estimated fair value. The current Buyback Yield % is -0.01. Genus' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Genus (CHIX:GNSL), the current Buyback Yield % is -0.01 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genus (CHIX:GNSL) Overvalued in 2026?

Based on GuruFocus' analysis, Genus stock appears to be overvalued. The current stock price of £21.42 is trading 3.8% above its estimated GF Value™ of £20.63. GuruFocus considers Genus to be Fairly Valued.

Key valuation signals for CHIX:GNSL:

  • Buyback Yield %: -0.01
  • GF Value™: £20.63 vs. price of £21.42 (3.8% above fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the CHIX:GNSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Genus Business Description

Address Matrix House, Basing View, Basingstoke, Hampshire, GBR, RG21 4FF
Genus PLC is an animal genetics company focused on improving cattle and pig populations to support sustainable food production. The company operates through two main business units: one providing bovine genetics mainly for dairy and beef cattle, and the other offering porcine genetics for pork production. Genus develops genetically superior breeding animals using scientific techniques. It generates revenue by selling genetics, including semen and embryos, as well as through related services under multi-year royalty agreements. The principal activities of each segment are: (a) Genus PIC porcine sales business, (b) Genus ABS: bovine sales business, and (c) Genus Research and Development: spending on research and development.
72GF Score

Get the complete analysis for CHIX:GNSL

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£21.42
Price
£20.63
GF Value